The article discusses the use of dexamethasone as an adjuvant to local anesthetic solution for ultrasound (US)-guided femoral nerve block in patients after total knee joint replacement. A literature review on the clinical use of other adjuvants is also presented.
corded complications in the implementation of peripheral nerve blocks.
When performing a peripheral nerve block, single shot or continuous infusion through a perineural catheter in modern anesthesia is recommended, two local anesthetics are recommended to be instilledlevobupivacaine and ropivacaine. Their widespread popularity in contemporary regionalism is due to their safe profile in continuous infusion, lower cardiotoxicity and hemodynamic stability with lidocaine and bupivacaine, lack of neurotoxicity and demyelinating processes (1, 2) and, of course, their prolonged effect.
Numerous reports and studies to compare analgesic potency, duration, concomitant motor block to determine optimal local anesthetic, concentration, bolus volume, and speed and infusion concentration are present in the literature.
With regard to the addition of adjuvants to the local anesthetic, the use of vasoconstrictors is observed due to the risk of ischemic damage to the peripheral nerves caused by vasoconstriction of vasa nervorum.
The results for clonidine and dexmedetomidine are controversial, both in terms of the potential and prolonging effects, the occurrence of frequent undesirable hypotensive (3) , and in case of doubt about the possible toxic effect of clonidine in peripheral nerves experimentally in animals.
More good results in the literature refer to dexmedetomidine (4) . Clinical trials establish a real prolongation of peripheral nerve blocks (PNBs) with the addition of 100 mcg of dexmedetomidine to a local anesthetic but there is frequent bradycardia requiring medication (5) .
Absolute apogee in the literature was observed with the discovery of beneficial and potentiating effects of dexamethasone, administered both as an adjuvant to the local anesthetic in single shot PNBs and in direct intravenous application (6, 7, 8) .
Applied as an adjuvant, a significantly prolonged analgesic effect over 200 minutes and better results in the evaluation of postoperative pain on validated scales (VAS) (9, 10, 11, 12) is registered. In the last 2-3 years, the addition of dexamethasone adjuvant to a solution of a long-acting local anesthetic in performing PNBs is a tendency to avoid peri-
INTRODUCTION "The art of life is the art of avoiding pain"
Thomas Jefferson
Optimal control of perioperative pain continues to be a major challenge for physicians, anesthetists, intensive care specialists and surgeons. It allows the reduction of patient suffering and maximum satisfaction, early mobilization, shortened hospital stay, reduced registered complications, morbidity and mortality.
Major surgery is associated with severe perioperative stress on the body, reflecting both the physical condition as well as the psychological aspect of the individual and the quality of life of the patient.
Effective pain control in the perioperative and early postoperative period has a lower incidence of complications such as postoperative respiratory failure, deep vein thrombosis and pulmonary thromboembolism, lower cardiac risk, nosocomial infections, and postoperative delirium. Good pain control results in reduced hospital stays leading to the corresponding economic benefits and, last but not least, a better quality of life.
Ultrasound (US)-guided nerve blocks are a modern, safe, reliable method for perioperative and postoperative analgesia that allows the reduction of the use of more invasive methods -epidural analgesia, drastic reduction of doses of the applied opiates with all the resulting negative effects -nausea, vomiting, itching, constipation, attenuated immunological response, respiratory depression, sleepiness, etc.
Peripheral nerve block of n. femoralis under US control is a modern method allowing good perioperative pain control, early physiotherapy and mobilization, a lower incidence of postoperative complications observed in patients after prosthetic knee joint replacement. All of the above-mentioned benefits make it a preferential method for postoperative analgesia in the early postoperative period. It provides a low-risk blockade with no absolute contraindications. It is also applied in patients with coagulation disorders.
US navigation allows a modern, fast, non-traumatic and reliable method, a low frequency of re-neural catheters as a more invasive method related to the risk of infection, nerve damage, frequent dislocation and migration into other anatomical spaces. Other drawbacks of catheter techniques are the higher cost, the requirement of a particular logistics organization, and more highly skilled staff, respectively.
Ethiopathogenetically, the effect of dexamethasone is most likely due to induced vasoconstriction and prolongation of local anesthetic activity and, on the other hand, to reduced nociceptive sensitivity of C-fibers through direct effect on glucocorticoid receptors and inhibition of potassium channels, and possible systemic anti-inflammatory effect (13, 14) .
Dexamethasone primarily affects dynamic pain, and its use does not increase the risk of wound infection (15) .
In 2015, Ke An and co-authors (16) cite other possible beneficial effects of dexamethasone added as an adjuvant. They reported transient neurotoxic activity and reduced reversible hyperalgesia following depletion of the block effect. Others, like Fredrickson Fanzca MJ and co-authors, consider that all these claims are subject to reassessment and the data on the described effects are not convincing enough (17, 18) .
Regarding the dose of dexamethasone as an adjuvant to a local anesthetic solution, the majority of the authors consider that the higher dose does not lead to a greater prolongation of the blockade or better analgesia, but only increases the risk of systemic effects of corticosteroids. Doses of 4 mg and 8 mg dexamethasone were compared, with no significant difference in the quality of the block (9) . The use of dexamethasone as part of a multimodal pain management strategy has been the subject of much discussion in recent years. Almost all clinicians are behind the fact that it most likely affects the management of pain. Questions are asked about its intravenous application, whether epidural or perineural application is better, or what the dosage and duration of application should be. There are questions about the the exact mechanism of action, and the existence of adverse effects -early or late ones. Authors cite that, applied intravenously, dexamethasone again prolongs the effect of peripheral nerve blockade (20).
Author Primary Outcome Analgesia Duration

Block Analgesia Quality
In 2016, Chun EH et al. conducted a study of two groups of patients who had an intercellular block for arthroscopic surgery on the shoulder joint. Dexamethasone 5 mg is used on both groups -intravenously on one, and perineurally on the other. The results that they cite are definitely in favor of perineural application of dexamethasone, only there is a significant prolongation of the block with approximately 200 min. Another study done with 4 mg dexamethasone with one-way results (19) is similar in design.
Some authors share good results in knee replacement patients who received ketamine intravenous infusion 3 mcg/kg/min intraoperatively and 1.5 mcg/kg/min 48h postoperatively. Ketamine influences the intensity of pain as well as prevents central pain sensitization. The use of ketamine reduces morphine consumption and shortens the time for patients to achieve 90 degrees of flexion on the knee joint. These authors suggest its application to regional femoral block (FB) techniques or epidural analgesia (21, 15) .
Several reports in the literature on topic adjuvants to local anesthetics commented on magnesium sulphate as a prolonged PNB agent and better results on the visual acuity scale (VAS) pain assessment and a total dose of added analgesics (22,23). Magnesium demonstrates an antinociceptive effect in animal models and in humans. The antinociception effect is due to regulation of calcium influx. In the literature, there are various design studies where magnesium has been applied epidurally and the authors have registered a beneficial effect after its use with regard to opioid consumption and the extent of pain reported, i.e. co-administration of magnesium results in a better analgesic effect (24,25).
A study from 2008 compares three control groups of patients with femoral perineural catheters infused with 0.2% ropivacaine 0.2%, ropivacaine 0.2% + fentanyl 4 μg/mL and ropivacaine 0.2% + 50 mg/mL, respectively. The authors report a better and prolonged analgesic effect in the two adjuvants of fentanyl and magnesium, respectively, with the results in both groups being comparable (26).
Other authors deny the antinociceptive effect of fentanyl administered perineurally, indicating no significant difference in the outcome (27).
It is still unclear in the literature whether perineural application of an opioid (fentanyl) has a beneficial effect on PNBs. Clinicians share a potentiating analgesic potency of 100 mcg of fentanyl added to a local anesthetic while performing an axillary block. They report a significant difference in the degree of analgesia, but also share a delayed onset of the block, as the most likely cause of this fact indicates a decrease in the pH of the fentanyl solution (28).
Until now, no theoretical rationale for the possible mechanism of action of perineural application of opioid has been found in the literature. In the axonal membrane of the afferent peripheral, nerve opioid receptors are absent. Following the physiological and pathophysiological mechanisms, the use of an opioid adjuvant to a local anesthetic for peripheral nerve blocking appears to be illogical (29).
It is very likely that the superficial analgesic effect reported, which in some patients is observed to be due to the systemic action of the opioid rather than the local one. To confirm a possible peripheral effect of opiates, sophisticated preclinical and clinical studies should be performed to justify the physiological and pathophysiological justification of possible beneficial results (27).
Studies comparing potential beneficial effects and possible neurotoxicity and other adverse effects do not support regular use in daily medical practice as adjuvants to local anesthetics, midazolam, magnesium, dexmedetomidine, and ketamine (30). Other authors set the question whether the addition of any adjuvant places the patient at an unnecessary risk without a certain benefit (30). At the moment, in the official marketing authorizations of all the adjuvants discussed above, the perineural method of administration of the medication is not present (31).
AIM
The aim of this article is to investigate the effect of a dexamethasone adjuvant on the local anesthetic solution when performing a US-guided femoral block in patients after knee joint replacement.
MATERIALS AND METHODS
The scientific study was conducted at the Anesthesiology and Intensive Care Clinic and in the Orthopedic Clinic of the St. Marina University Hospital in the period from 2012 until 2017.
All patients treated in the Anesthesiology and Intensive Care Clinic were fasted by one of the following methods:
Femoral block -long infusion through perineural catheter + NE opioid + SOS opioid.
Single shot femoral block + NE opioid + SOS opioid. Two groups were formed, one of which with two subgroups:
Group 1: single shot FNB + constant infusion through a perineural catheter 15 mL bolus (ropivacaine 0.5%/levobupivacaine 0.375%) with a subsequent infusion of 5-9 mL per hour. The group consisted of 20 patients.
Group 2: single shot FNB 20 mL bolus (ropivacaine 0.5%/levobupivacaine 0.375%) ± dexamethasone 4 mg. The group consisted of 33 patients. In this group, 2 subgroups were formed: patients with single shot FNB with chirocain -10 patients; patients with single shot FNB with ropivacaine -23 patients. Of these, 15 patients were fasted with single shot FNB with ropivacaine + dexamethasone 4 mg, 8 patients with pure ropivacaine.
Evaluation of effective control of pain relief symptoms on 2nd, 4th, 6th, 12th, 18th, 24th, and 36th hours postoperatively was done according to VAS.
RESULTS
Comparison of the results in the VAS score in the two groups: Group 1 -single shot FNB + constant infusion through perineural catheter and Group 2single shot FNB ± dexamethasone.
No statistically significant difference in VAS values was observed with the use of a catheter in the 2 nd , 6 th , 12 th , 18 th and 36 th hours. Such was found only in the 24 th hour.
The curves practically overlap until the 18th hour, after which the patients with perineural catheter and a constant infusion of local anesthetic show a lower VAS score at the 24 th and 36 th hour.
Statistically significant is the difference only at the 24 th hour. Our results reported an advantage of It should be noted that the 24 th postoperative hour is the time for starting verticalization and rehabilitation of the patients in the Orthopedic Clinic at the St. Marina University Hospital, i.e. the muscular weakness of m. quadriceps femoris would be undesirable at this time.
Such a view of "single shot" preference technique is expressed in the Heeremans EH et al., 2012. Adding the higher price, time consumption, the requirements for higher qualification of the service staff (32), we think that for primary prosthesis the single shot FNB technique is more appropriate, with a view to early patient verticalization and rehabilitation, an early post-operative period outside of Anesthesiology and Intensive Care Clinic and a lower infection risk. Permanent catheter techniques are believed to be suitable for secondary and tertiary interventions that are more traumatic in which patients are in an Anesthesiology and Intensive Care Clinic and in which early verticalization and rehabilitation do not begin because of joint instability.
Effect of Dexamethasone on VAS Score
In 2015, based on the literature, we decided to start administering 4 mg of dexamethasone to the local anesthetic solution at the time of the PNB. In this study, 15 patients in the single shot FNB group + ropivacaine had dexamethasone added as an adjuvant. Data processing reported a statistically significant difference after the 18 th hour, also in the 24 th and 36 th , but they did not in benefit from dexamethasone (Fig.  2 ). The reported difference was a minimum <0.5 of the VAS score, which is within the error of the inquiry method and is of no clinical significance. We did not detect statistically significant benefits of this adjuvant. We did not have clinically registered ADRs. We have not established a correlation between these occurrences and the use of dexamethasone.
A statistically significant difference was observed in the 24 th and 36 th hours, and after the 18th hour.
CONCLUSION
Although our results correspond to those of authors who refute the positives of dexamethasone (12, 25) as an adjunct to PNB, we believe, based on clinical observation data, that it actually attenuated reversible hyperalgesia (patients did not report abrupt, acute, sudden onset of pain), therefore prolongation of the analgesic effect was observed until the 18 th , 20 th postoperative hour. 
